Related Experiment Video
Updated: Mar 12, 2026

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
Published on: March 17, 2023
Architecting NIR-II metal supramolecular dyes-illuminating the path to precision medicine
Fang Zhao1,2,3, Qiao Song2, Panxing Qiu2
1Department of Neurosurgery, Jiujiang City Key Laboratory of Cell Therapy/Human Genetic Resources Innovation Center, The First Hospital of Jiujiang City Jiujiang 332000 China yjtang0808@163.com.
Abstract:
Precision medicine calls for molecular tools that enable high-resolution imaging at depth, accurate lesion localisation and controllable therapy. Small-molecule dyes are widely used in biomedical imaging and treatment, yet their limited photostability, susceptibility to quenching in physiological environments and rapid in vivo clearance continue to hinder clinical translation. Coordination-driven supramolecular chemistry offers a promising route to address these shortcomings. However, progress in in vivo delivery and biodistribution, real-time visual tracking and therapeutic evaluation has often been constrained by short-wavelength excitation and emission. In this context, second near-infrared (NIR-II) metal supramolecular dyes assembled directly from NIR-II ligands have been rapidly developed, furnishing platforms with strong NIR-II performance and tunable photophysical behaviour. This perspective summarises design and construction strategies for NIR-II metal supramolecular dyes, highlights their key photophysical characteristics, and surveys representative applications in cancer, antibacterial and cardiovascular theranostics and imaging. We further discuss outstanding challenges for clinical translation and outline future opportunities for NIR-II metal supramolecular dyes in precision medicine.

